News
TKNO
4.400
-3.51%
-0.160
Weekly Report: what happened at TKNO last week (0902-0906)?
Weekly Report · 09/09 11:28
Weekly Report: what happened at TKNO last week (0826-0830)?
Weekly Report · 09/02 11:32
Conestoga Capital Advisors Q2 2024 Commentary
Seeking Alpha · 08/28 11:05
Weekly Report: what happened at TKNO last week (0819-0823)?
Weekly Report · 08/26 11:29
ALPHA TEKNOVA INC FILES FOR OFFERING OF UP TO 12.4 MLN SHARES BY THE SELLING STOCKHOLDERS - SEC FILING
Reuters · 08/23 20:53
Weekly Report: what happened at TKNO last week (0812-0816)?
Weekly Report · 08/19 11:16
U.S. RESEARCH ROUNDUP-Allstate, bluebird bio , Vicinity Motor
Reuters · 08/15 06:57
ALPHA TEKNOVA INC <TKNO.O>: STEPHENS RAISES TARGET PRICE TO $5 FROM $4
Reuters · 08/15 05:25
Wednesday Sector Laggards: Advertising, Diagnostics
NASDAQ · 08/14 16:04
Alpha Teknova’s Stabilizing Operations and Growth Prospects Justify Buy Rating
TipRanks · 08/14 02:15
TKNO Stock Earnings: Alpha Teknova Beats EPS, Beats Revenue for Q2 2024
Investorplace · 08/14 00:56
Alpha Teknova GAAP EPS of -$0.13 beats by $0.03, revenue of $9.6M beats by $0.02M
Seeking Alpha · 08/13 20:15
*Alpha Teknova Backs 2024 Rev Guidance of $35M-$38M
Dow Jones · 08/13 20:04
*Alpha Teknova 2Q Rev $9.61M >TKNO
Dow Jones · 08/13 20:03
*Alpha Teknova 2Q Loss/Shr 13c >TKNO
Dow Jones · 08/13 20:03
BRIEF-Alpha Teknova Q2 EPS USD -0.13
Reuters · 08/13 20:01
Alpha Teknova: Q2 Earnings Snapshot
Barchart · 08/13 15:10
Weekly Report: what happened at TKNO last week (0805-0809)?
Weekly Report · 08/12 11:18
Weekly Report: what happened at TKNO last week (0729-0802)?
Weekly Report · 08/05 11:29
Weekly Report: what happened at TKNO last week (0722-0726)?
Weekly Report · 07/29 11:18
More
Webull provides a variety of real-time TKNO stock news. You can receive the latest news about Alpha Teknova through multiple platforms. This information may help you make smarter investment decisions.
About TKNO
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.